Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023)

Ginkgo Bioworks Holdings (DNA) reported Change in Working Capital of $4.7 million for Q2 2023, up 76.52% on a YoY basis from $2.7 million in Q2 2022, and down 44.5% quarter-over-quarter from $8.5 million in Q1 2023.

Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023) Analysis & Trends

Ginkgo Bioworks Holdings has reported Change in Working Capital for 2 years, with the latest figure at $4.7 million in Q2 2023.

  • For the quarter ending Q2 2023, Change in Working Capital rose 76.52% year-over-year to $4.7 million; the trailing twelve-month figure through Jun 2023 stood at $18.6 million (changed N/A YoY), and the FY2022 full-year result was $10.8 million, changed N/A from the prior year.
  • Change in Working Capital for Q2 2023 stood at $4.7 million, down from $8.5 million in the prior quarter.
  • The five-year high for Change in Working Capital was $8.5 million in Q1 2023, with the low at $2.7 million in Q1 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ginkgo Bioworks Holdings 546.79 Mn 546.79 Mn 16.38 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 4.73 Mn
Jun 30, 2023 4.73 Mn
Mar 31, 2023 8.52 Mn
Mar 31, 2023 8.52 Mn
Jun 30, 2022 2.68 Mn
Jun 30, 2022 2.68 Mn
Mar 31, 2022 2.65 Mn
Mar 31, 2022 2.65 Mn